COX-2 inhibitors. A new class of antiangiogenic agents

Annals of the New York Academy of Sciences

Volumn 889, Issue , 1999, Pages 84-86

  Masferrer, Jaime L ^a,b   Koki, Alane ^a   Seibert, Karen ^a  

^a PFIZER INC   (United States)

^b Discovery Pharmacology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 [5 (4 CHLOROPHENYL) 3 TRIFLUOROMETHYL 1H PYRAZOL 1 YL]BENZENESULFONAMIDE; 5 (4 CHLOROPHENYL) 1 (4 METHOXYPHENYL) 3 TRIFLUOROMETHYL 1H PYRAZOLE; ANGIOGENESIS INHIBITOR; BASIC FIBROBLAST GROWTH FACTOR; CARRAGEENAN; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2 INHIBITOR; INDOMETACIN; MATRIGEL; POLYMACON; UNCLASSIFIED DRUG; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; CANCER INHIBITION; CONFERENCE PAPER; CONTROLLED STUDY; CORNEA; DOSE RESPONSE; ENZYME ACTIVITY; GASTROINTESTINAL TOXICITY; MOUSE; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; SLIT LAMP;

ANIMALIA;

EID: 0033451177     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.1999.tb08726.x     Document Type: Conference Paper

References (7)

1. 1. Hanahan, D. & J. Folkman. 1996. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 86: 353-364.
2. 2. Needleman, P., J. Turk, B.A. Jakschik et al. 1986. Arachidonic acid metabolism. Annu. Rev. Biochem. 55: 69-102.
3. 3. Levy, G.N. 1997. Prostaglandin H synthases, nonsteroidal anti-inflammatory drugs and colon cancer. FASEB J. 11: 234-247.
4. 4. Crofford, L.J., R.L. Wilder, A.P. Ristimaki et al. 1994. Cyclooxygenase-1 and -2 expression in rheumatoid synovial tissues. Effects of interleukin-1 beta, phorbol ester and corticosteroids. J. Clin. Invest. 93: 1095-1101.
5. 5. Form, D.M. & R. Auerbach. 1983. PGE2 and angiogenesis. Proc. Soc. Exp. Biol. Med. 172: 214-218.
6. 6. Koki, A.T., D.A. Edwards, A.J. Dannenbergh et al. 1998. Cyclooxygenase-2 is expressed in animal and human cancers. Proc. Annu. Meet. Am. Assoc. Cancer Res. 39: Abstr. 1022.
7. 7. Reddy, B.S., C.V. Rao & K. Seibert. 1996. Evaluation of cyclooxygenase-2 inhibitor for potential chemopreventive properties in colon carcinogenesis. Cancer Res. 56: 4566-4569.